iHuman Inc.
New York Stock ExchangeTotal Valuation
iHuman Inc. carries a market capitalization of 14.54M, placing it among publicly traded companies globally. Its enterprise value stands at -605.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.54M |
| Enterprise Value | -605.44M |
Share Statistics
iHuman Inc. currently has 255.56M shares outstanding.
| Shares Outstanding | 255.56M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
iHuman Inc. trades at a trailing price-to-earnings ratio of 6.59. The price-to-sales ratio is 0.62, and the price-to-book ratio stands at 21.46.
| PE Ratio | 6.59 |
| PS Ratio | 0.62 |
| PB Ratio | 21.46 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 1.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.00 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.22 |
| EV / EBITDA | 13.00 |
| EV / EBIT | 13.00 |
| EV / FCF | N/A |
Financial Position
iHuman Inc. maintains a current ratio of 3.50, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.50 |
| Quick Ratio | 3.21 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 0.31 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 5.44 |
| Return on Invested Capital (ROIC) | 3.49 |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 10.83 |
Taxes
Over the trailing twelve months, iHuman Inc. has paid 3.32M in income taxes, reflecting an effective tax rate of 4.32.
| Income Tax | 3.32M |
| Effective Tax Rate | 4.32 |
Stock Price Statistics
iHuman Inc.'s stock has declined approximately -49.10394% over the past 52 weeks. The 50-day moving average sits at 1.50, while the 200-day moving average is 2.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -49.10394% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 2.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, iHuman Inc. generated 779.08M in revenue and converted that into 73.40M in net income, yielding earnings per share of 1.72. EBITDA reached 35.07M, while operating income came in at 35.07M.
| Revenue | 779.08M |
| Gross Profit | 525.81M |
| Operating Income | 35.07M |
| Pretax Income | 76.72M |
| Net Income | 73.40M |
| EBITDA | 35.07M |
| EBIT | 35.07M |
| Earnings Per Share (EPS) | 1.72 |
Balance Sheet
iHuman Inc. holds 1.10B in cash and equivalents against 10.97M in total debt, resulting in a net debt position of -356.48M. Total book value stands at 22.53M, with working capital of 899.03M providing operational flexibility.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 10.97M |
| Net Debt | -356.48M |
| Equity (Book Value) | 22.53M |
| Book Value Per Share | 0.55 |
| Working Capital | 899.03M |
Margins
iHuman Inc. operates with a gross margin of 67.49, reflecting its pricing power and cost economics. The operating margin of 4.50 and net profit margin of 9.42 provide insight into operational efficiency.
| Gross Margin | 67.49 |
| Operating Margin | 4.50 |
| Pretax Margin | 9.85 |
| Profit Margin | 9.42 |
| EBITDA Margin | 4.50 |
Scores
iHuman Inc. posts an Altman Z-Score of 2.32, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.32 |